Doxofylline: The next generation methylxanthine

Indian Journal of Pediatrics

Volumn 75, Issue 3, 2008, Pages 251-254

  Sankar, Jhuma ^a   Lodha, Rakesh ^a   Kabra, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bronchial asthma; Children; Doxofylline; Theophylline

Indexed keywords

CYCLIC AMP; DOXOFYLLINE; METHYLXANTHINE DERIVATIVE; PHOSPHODIESTERASE; PLACEBO; THEOPHYLLINE;

ADD ON THERAPY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; CHRONOTROPISM; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; IMMUNOMODULATION; INDIA; INSOMNIA; LIVER FAILURE; NAUSEA; PATIENT COMPLIANCE; PREVALENCE; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SLEEP DISORDER; SPIROMETRY; STOMACH SECRETION; TREMOR; VOMITING;

ASTHMA; BRONCHODILATOR AGENTS; CHILD; HUMANS; THEOPHYLLINE;

EID: 44049090276     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-008-0054-1     Document Type: Review

References (17)

1. Global initiative for asthma (GINA). Global strategy for asthma management and prevention. Revised 2006. www.ginasthma.org.
2. st ed. Delhi; Noble Vision 2006; 123-143.
3. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994; 7: 579-591
4. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med 1996; 334: 1380-1388.
5. Bierman CW, William PV. Therapeutic monitoring of theophylline: rationale and current status. Clin Pharmacokinet 1989; 17: 377-384.
6. Franzone JS, Cirillo R, Barone D. Doxofylline and theophylline are xanthines with partly different mechanisms of action in animals. Drug Exp Clin Res 1988; 14: 479-489
7. Bagnato G, Fodale P, Bottari M. Clinical evaluation of doxofylline sachets in a pediatric population. Riv Eur Sci Med Farmacol 1989; 11: 359-363.
8. Bagnato GF. Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma. Eur Rev Med Pharmacol Sci 1999; 3: 255-260.
9. Melillo G et al. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial. Int J Clin Pharmacol Res 1989; 9: 397-405.
10. Goldstein MF, Chervinsky P. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma - a double-blind randomised placebo-controlled multicentre clinical trial. Med Sci Monit 2002; 8: 297-304
11. Dini, FL Cogo R. Doxofylline: A new generation xanthine brochodilator devoid of major cardiovascular adverse effects. Curr Med Res Opin 2001; 16: 258-268.
12. Poggi R, Brandolese R, Bernasconi M et al. Doxofylline and respiratory mechanics. Short-term effects in mechanically ventilated patients with airflow obstruction and respiratory failure. Chest 1989; 96: 772-778.
13. Bologna E, Laganà A, Terracino D, Bolignari P, Biffignandi P. Oral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitis. J Int Med Res 1990; 18: 282-288.
14. Dolcetti A, Osella D, De Filippis G, Carnuccio C, Grossi E. Comparison of intravenously administered doxofylline and placebo for the treatment of severe acute airways obstruction. J Int Med Res 1988; 16: 264-269.
15. Lazzaroni M, Grossi E, Banchi PG. The effect of intravenous doxofylline or aminophylline on gastric secretion in duodenal ulcer patients. Aliment Pharmacol Therapy 1990; 4: 643-649.
16. Cipri A, Pozzar F, Dini FL. Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs. Minerva Cardioangiol 1992; 40: 31-39.
17. Sacco C, Braghiroli A, Grossi E et al. The effects of doxofylline versus theophylline on sleep architecture in COPD patients. Monaldi Arch Chest Dis 1995; 50: 98-103